http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106636007-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 |
filingDate | 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106636007-B |
titleOfInvention | Anti- USP2a protein monoclonal antibody hybridoma and its anti-USP2a monoclonal antibody and application of generation |
abstract | The invention discloses a kind of anti-USP2a protein monoclonal antibody hybridoma and its anti-USP2a monoclonal antibodies and application of generation.Strain of hybridoma strain disclosed by the invention, is named as hybridoma cell strain 3D9, is preserved in China typical culture collection center, and deposit number is CCTCC NO:C2016186;Hybridoma cell strain 3D9 secretion produces the monoclonal antibody of anti-USP2a;The monoclonal antibody of the anti-USP2a can be applied in tumor tissue section's Immunohistochemical detection.The monoclonal antibody for the anti-USP2a that hybridoma cell strain 3D9 secretion of the invention generates has the characteristics that potency is high, property is stable and high specificity. |
priorityDate | 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 308.